Work

A randomized phase II study of pazopanib in castrate-sensitive prostate cancer: A University of Chicago phase II consortium/DoD Prostate Cancer Clinical Trials Consortium study.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.7_suppl.170

Authors: J. E. Ward, S. Limvorasak, T. Karrison, G. S. Chatta, M. Hussain, D. H. Shevrin, R. Z. Szmulewitz, W. M. Stadler, E. M. Posadas

Institutions: University of Michigan, University of Chicago Medical Center, University of Pittsburgh Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560236377

Cites:

Cited by:

Related to: 10